<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Global Blood Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc. (GBT) is a clinical-stage biopharmaceutical dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its late-stage product candidate, voxelotor (GBT440), for the treatment of sickle cell disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $540,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Ted W. Love, M.D.
    • FOUNDED
      2012
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Intrexon Corporation

    Intrexon Corporation

    Intrexon Corporation (NASDAQ: XON) is Powering the Bioindustrial Revolution with B...

    Intrexon Corporation (NASDAQ: XON) is Powering ...

    Filing Type:    PU
    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the deve...

    Citius Pharmaceuticals is a specialty pharmaceu...

    Filing Type:    PU
    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc.

    G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on th...

    G1 Therapeutics, Inc., is a clinical-stage biop...

    Filing Type:    PU
    Avid Bioservices, Inc.

    Avid Bioservices, Inc.

    Avid Bioservices is a dedicated contract development and manufacturing organizatio...

    Avid Bioservices is a dedicated contract develo...

    Filing Type:    PU
    Geron Corporation

    Geron Corporation

    Geron is a late-stage clinical biopharmaceutical company focused on the developmen...

    Geron is a late-stage clinical biopharmaceutica...

    Filing Type:    PU
    ContraFect Corporation

    ContraFect Corporation

    ContraFect is a clinical-stage biotechnology company focused on discovering and de...

    ContraFect is a clinical-stage biotechnology co...

    Filing Type:    PU
    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals, Inc.

    Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncolo...

    Spectrum Pharmaceuticals is a leading biotechno...

    Filing Type:    PU
    CRISPR Therapeutics AG

    CRISPR Therapeutics AG

    We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...

    We are rapidly translating our specific, effici...

    Filing Type:    PU
    GlycoMimetics, Inc.

    GlycoMimetics, Inc.

    At GlycoMimetics, we are committed to helping to make a difference in the lives of...

    At GlycoMimetics, we are committed to helping t...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.